References
1. Paleri V, Urbano T, Mehanna H, Repanos C, Lancaster J, Roques T, et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology. 2016;130(S2):S161-S9.
2. Allanson BM, Low TH, Clark JR, Gupta R. Squamous Cell Carcinoma of the External Auditory Canal and Temporal Bone: An Update. Head Neck Pathol. 2018;12(3):407-18.
3. Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol. 2000;21(4):582-8.
4. Masterson L, Rouhani M, Donnelly NP, Tysome JR, Patel P, Jefferies SJ, et al. Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy. Otol Neurotol. 2014;35(3):501-8.
5. Roland N, Paleri V. Head and neck cancer: multidisciplinary management guidelines. Restorative Dentistry/Oral Rehabilitation London: ENT UK. 2011:56-62.
6. Paleri V, Roland N. Introduction to the United Kingdom national multidisciplinary guidelines for head and neck cancer. The Journal of Laryngology & Otology. 2016;130(S2):S3-S4.
7. Rinaldo A, Ferlito A, Suarez C, Kowalski LP. Nodal disease in temporal bone squamous carcinoma. Acta Otolaryngol. 2005;125(1):5-8.
8. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
9. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa. 2014.
10. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321-59.
11. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-55.
12. Chang CH, Shu MT, Lee JC, Leu YS, Chen YC, Lee KS. Treatments and outcomes of malignant tumors of external auditory canal. Am J Otolaryngol. 2009;30(1):44-8.
13. Cristalli G, Manciocco V, Pichi B, Marucci L, Arcangeli G, Telera S, et al. Treatment and outcome of advanced external auditory canal and middle ear squamous cell carcinoma. J Craniofac Surg. 2009;20(3):816-21.
14. Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the temporal bone. Laryngoscope. 2010;120(6):1144-51.
15. Matoba T, Hanai N, Suzuki H, Nishikawa D, Tachibana E, Okada T, et al. Treatment and Outcomes of Carcinoma of the External and Middle Ear: The Validity of En Bloc Resection for Advanced Tumor. Neurol Med Chir (Tokyo). 2018;58(1):32-8.
16. McRackan TR, Fang TY, Pelosi S, Rivas A, Dietrich MS, Wanna GB, et al. Factors associated with recurrence of squamous cell carcinoma involving the temporal bone. Ann Otol Rhinol Laryngol. 2014;123(4):235-9.
17. Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck. 2012;34(9):1231-9.
18. Ng SY, Pua KC, Zahirrudin Z. Temporal bone squamous cell carcinoma - Penang experience. Med J Malaysia. 2015;70(6):367-8.
19. Zanoletti E, Danesi G. The problem of nodal disease in squamous cell carcinoma of the temporal bone. Acta Otolaryngol. 2010;130(8):913-6.
20. Nakagawa T, Kumamoto Y, Natori Y, Shiratsuchi H, Toh S, Kakazu Y, et al. Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol. 2006;27(2):242-8; discussion 9.
21. Ogura JH, Biller HF, Wette R. Elective neck dissection for pharyngeal and laryngeal cancers. An evaluation. Ann Otol Rhinol Laryngol. 1971;80(5):646-50.
22. Lee JG, Krause CJ. Radical neck dissection: Elective, therapeutic, and secondary. Arch Otolaryngol. 1975;101(11):656-9.
23. Prasad SC, D’Orazio F, Medina M, Bacciu A, Sanna M. State of the art in temporal bone malignancies. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):154-65.
24. Mehta GU, Muelleman TJ, Brackmann DE, Gidley PW. Temporal bone resection for lateral skull-base malignancies. J Neurooncol. 2020;150(3):437-44.
25. Ferlito A, Rinaldo A, Silver CE, Gourin CG, Shah JP, Clayman GL, et al. Elective and therapeutic selective neck dissection. Oral Oncol. 2006;42(1):14-25.
26. Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM. Radiation-induced carotid artery atherosclerosis. Radiother Oncol. 2014;110(1):31-8.
27. Bacciu A, Clemente IA, Piccirillo E, Ferrari S, Sanna M. Guidelines for treating temporal bone carcinoma based on long-term outcomes. Otol Neurotol. 2013;34(5):898-907.
28. Zhang T, Li W, Dai C, Chi F, Wang S, Wang Z. Evidence-based surgical management of T1 or T2 temporal bone malignancies. Laryngoscope. 2013;123(1):244-8.
29. Seligman KL, Sun DQ, Ten Eyck PP, Schularick NM, Hansen MR. Temporal bone carcinoma: Treatment patterns and survival. Laryngoscope. 2020;130(1):E11-E20.
30. Xie B, Zhang T, Dai C. Survival outcomes of patients with temporal bone squamous cell carcinoma with different invasion patterns. Head Neck. 2015;37(2):188-96.
31. Ge X, Liao Z, Yuan J, Mao D, Li Y, Yu E, et al. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis. Support Care Cancer. 2020;28(6):2701-12.
32. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(7):873-98.